|
|
|
Although all new drugs have to be tested to get regulatory
approval, the same is not necessarily true for
medical devices. Jeanne Lenzer reports on
loopholes that are leaving patients at risk
The first 150 words of the
full text
of this article appear below. |
Lana Keeton was 54 when a surgeon used a synthetic mesh to
create a pubovaginal sling to treat her for
stress urinary incontinence. After her surgery in
2001, Ms Keeton developed a necrotizing soft
tissue infection at the operative site. Surgeons later
found that the mesh had migrated and eroded through
her bladder wall. During the past eight years, Ms
Keeton has had numerous procedures and operations
to remove pieces of the mesh and to treat
recurrent urinary tract infections and pain. In October
2008, the US Food and Drug Administration warned that
surgical meshes made by nine manufacturers,
including the manufacturer of the mesh implanted
in Ms Keeton, have been associated with serious
complications, including bowel and bladder perforations,
infections, and pain.1 Because of a little
known loophole in the device approval process,
the FDA did not require the manufacturers to
submit safety or efficacy data before receiving approval
. . . [Full
text of this article]
|
|